Global Endocrine Testing Market is expected to reach USD 13.02 billion by 2024. The endocrine system is a combined system that contains numerous glands situated throughout the body. Together with the nervous system, the endocrine system regulates and controls several internal physical functions. Although the nervous system uses nerve impulses as a means of control, the endocrine system uses chemical messenger molecules called hormones. With the help of network of glands, hormones are produced, stored, and secreted.
Thymus, adrenal glands, testes, hypothalamus, pituitary gland, ovaries, pineal gland, islet cells in the pancreas, thyroid, and parathyroid are glands of endocrine system. The endocrine testing market is estimated to grow at a significant CAGR of 8.0% over the future period as the scope and its applications are rising enormously across the globe.
Download Free Sample Report @ https://www.millioninsights.com/industry-reports/endocrine-testing-market/request-sample
Endocrine testing industry is segmented based on test type, technology, end use, and region. Insulin, estradiol (E2), cortisol, Follicle Stimulating (FSH), prolactin, Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone (TSH), Luteinizing Hormone (LH), testosterone, Dehydroepiandrosterone sulfate (DHEAS), progesterone, and other test type could be explored in endocrine testing market in the forecast period.
Thyroid Stimulating Hormone (TSH) sector accounted for the largest market share of endocrine testing industry and is estimated to lead the overall market in the coming years. This may be because of rising awareness regarding cardiovascular disorders and thyroid hormones levels. Moreover, insulin test is estimated to grow at fastest pace in the coming years, as growing diabetic population.
Highly used enhanced technology includes clinical chemistry, tandem mass spectrometry, sensor technology, immunoassay, monoclonal & polyclonal antibody technologies, and others that could be explored in the future period. During foremost period, the tandem mass spectrometry is estimated to lead the overall market. This may be because of rising use in combination with liquid chromatography. However, sensor technology segment is estimated to grow at fastest pace in the years to come, as rising use of biosensors in glucose monitoring for diabetes.
The market may be categorized based on end users like ambulatory care centers, hospital, commercial laboratory, and others could be explored in the foremost period. The hospital sector accounted for the largest market share and is estimated to continue its dominance in the forecast period. However, the commercial laboratory sector is estimated to grow at fastest pace in the coming years, as presence of skilled workers and accessibility of enhanced infrastructure.
Globally, North America accounted for the largest market share of endocrine testing and is estimated to continue its dominance in the upcoming years. The reason behind the overall market growth could be presence of advanced tertiary, secondary, and primary care hospitals, government initiative, enhanced compensation network, satisfactory government funding policy, and rising health awareness. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth.
Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR of 9.1% in the foremost period. The aspects that may be ascribed to the growth comprise rising R&D expenditure by private agencies and government to improve therapeutic and diagnostic areas in the region. The developing countries like India and China are the major consumers of endocrine testing industry in this region, as developing healthcare infrastructure and government compensation policies.
The key players of endocrine testing market are Quest Diagnostics, Abbott Laboratories, LabCorp., AB Sciex, Hoffmann-La Roche Ltd., Agilent Technologies, DiaSorin, Biomedical Technologies, Bio-Rad Laboratories, and bioMerieux SA. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Browse Full Research Report with TOC @ https://www.millioninsights.com/industry-reports/endocrine-testing-market
Market Segment:
Test Type Outlook (Revenue, USD Million, 2013 - 2024)
• Estradiol
• FSH
• hCG
• LH
• DHEAS
• Progesterone
• Testosterone
• TSH
• Prolactin
• Cortisol
• Insulin
• Others
Technology Outlook (Revenue, USD Million, 2013 - 2024)
• Tandem Mass Spectrometry
• Immunoassay
• Monoclonal & Polyclonal antibody technologies
• Sensor technology
• Clinical chemistry
• Others
End Use Outlook (Revenue, USD Million, 2013 - 2024)
• Hospital
• Commercial Laboratory
• Ambulatory Care Centers
• Others
Regional Outlook (Revenue, USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
Continued…
Get in Touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Transparency Market Research (TMR) () has published a new report titled, ‘Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global endocrine testing market was valued at US$ 5.5 Bn in 2018 and is projected to expand at a CAGR of 6.4% from 2019 to 2027.Read Report Overview - https://www.transparencymarketresearch.com/endocrine-testing-market.html OverviewEndocrine system is made up of endocrine glands that secrete hormones directly into the blood stream.
they help detect either hypersecretion (excess secretion) or hyposecretion (less secretion) that results in certain endocrine disorders such as infertility, menopause, thyroid dysfunction and others.The Endocrine Testing market is currently booming one, owing to consistent rise in diabetic and obese population resulting in development of several health disorders thereby enhancing the growth and acceptance of endocrine test kits and methodologies.
Moreover endocrine test kit manufacturers are focusing on the development of efficient diagnostic test kits of high accuracy which are the factors anticipated to drive the growth of market.North America dominates the global endocrine testing market in 2018 and the trend is anticipated to continue during the forecast period.
The growth of market in the region is attributed to increasing obesity and changing lifestyle and less physical inactivity resulting in several endocrine disorders., Also, increasing incidences of diabetes worldwide followed by constant technological upgradation in testing further propel the growth and adoption of endocrine testing platforms.Asia Pacific is likely to be a highly lucrative market for the Endocrine Testing market and it is expected to expand at a high CAGR during the forecast period.
Vast patient pool, increasing healthcare expenditure and demand for newer advanced therapies are key factors likely to boost endocrine testing market in Asia Pacific.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1645Rise in Prevalence of Endocrine and Metabolic Disorders to Drive Global Endocrine Testing MarketDisorders such as hypothyroidism, hyperthyroidism, diabetes mellitus, polycystic ovary syndrome (PCOS) among others are the most common endocrine & metabolic disorders among the global population.
A novel research report on Global Endocrine Testing Systems Market has been recently published by Reports and Data covering latest trends and key market developments during the forecast period from 2018 to 2026.
The report offers an in-depth analysis of forecast insights, market size, emerging trends, revenue growth, top companies, growth factors, restraints and opportunities in the global Endocrine Testing Systems market.
The report also offers an accurate analysis of competitive landscape, sales statistics and regional manufactures.
The data has been extracted through extensive research and is further validated by professionals and experts in the industry.
The report uses charts, graphs, tables and figures to visually reflect the statistical data collected and makes it easier for readers to understand the market situation.
The report also provides insights of the top key companies operating the market.Request Free Sample: https://www.reportsanddata.com/sample-enquiry-form/2240 Increasing incidence of diabetes, sedentary lifestyle, growing healthcare awareness, increasing government support & obesity are some of the key factors projected to surge the demand for Endocrine testing, thereby propelling the market growth.
Endocrine Testing Market is expected to reach USD 13.02 billion by 2024.
With the help of network of glands, hormones are produced, stored, and secreted.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/endocrine-testing-market/request-sample The key driving factors responsible for the growth of Endocrine Testing market : Thymus, adrenal glands, testes, hypothalamus, pituitary gland, ovaries, pineal gland, islet cells in the pancreas, thyroid, and parathyroid are glands of endocrine system.
The endocrine testing market is estimated to grow at a significant CAGR of 8.0% over the future period as the scope and its applications are rising enormously across the globe.
Insulin, estradiol (E2), cortisol, Follicle Stimulating (FSH), prolactin, Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone (TSH), Luteinizing Hormone (LH), testosterone, Dehydroepiandrosterone sulfate (DHEAS), progesterone, and other test type could be explored in endocrine testing market in the forecast period.
Thyroid Stimulating Hormone (TSH) sector accounted for the largest market share of endocrine testing industry and is estimated to lead the overall market in the coming years.
The global Endocrine Testing market report published by Reports and Data offers a comprehensive overview of the market dynamics and recent events in the industry to help the user/reader to understand the market scenario.
The report provides an assessment of emerging and current market trends, drivers, constraints, limitations, and opportunities that are may occur during the forecast period.
The statistical data is well-presented in form of diagrams, charts, tables, and other pictorial presentations for better user readability.
Increasing awareness about green energy and eco-friendly biodegradable products, environmental impact due to carbon emissions are few key factors supporting market growth.
In addition, increasing research and development activities, growing demand for products like perfumes, soaps, and detergents for daily usage along with rising disposable income across the globe are further boosting the market growthGet a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2240Competitive Landscape:Industry players in the Endocrine Testing market are adopting the strategy of forwarding integration to cater to increasing product demand and to enhance their footprint in the global market.This market report provides details of new recent developments, import-export analysis, trade regulations, production analysis, value chain optimization, market share, analyses opportunities in terms of emerging revenue pockets, the impact of domestic and localized market players, changes in the market, trends, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market.
The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.Regional Outlook:North America is expected to dominate the global materials and chemicals market landscape during the forecast period owing to the strong presence of prominent industry players in this region.
